![]() Xilio Therapeutics Xilio Therapeutics (formerly Akrevia Therapeutics) is a biopharmaceutical company focused on developing targeted immuno-oncology therapeutics. | OncoArendi Therapeutics OncoArendi Therapeutics is a biotech company focused on discovery and development of small molecule drug candidates. | ||
Founding Date | Founding Date 2001 | Founding Date 2015 | Founding Date 2012 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Lund, SE HQ | Locations Waltham, US HQ | Locations Warszawa, PL HQ Łódź, PL |
Employees | Employees 1555% decrease | Employees 69 | Employees 839% increase |
Valuation ($) | Valuation ($) 59 m | Valuation ($) 43.5 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) kr514k (FY, 2025) | Revenue (est.) $43.8m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income (kr51.4m) (FY, 2025) | Net income ($35m) (FY, 2025) | Net income N/A |

Xilio Therapeutics (formerly Akrevia Therapeutics) is a biopharmaceutical company focused on developing targeted immuno-oncology therapeutics.
View companyOncoArendi Therapeutics is a biotech company focused on discovery and development of small molecule drug candidates.
View company